Skip to main content

Service navigation

  • Contact
  • Become a member
  • Member portal
Menu
Home

Hoofdnavigatie

  • Domains
    • Human Health
    • Planetary Health
  • Members
  • Benefits
  • Funding
    • Project Call 2026.2
    • Intercluster cSBO call
    • Find a partner
  • Roadmaps
  • What's new
    • News
    • Events
    • Jobs
    • Science for Health
    • HealthTech Investor Summit
  • About Biovia
    • Mission & vision
    • Boards
    • Team

Discover the latest news in health innovation

Category

  • (-) Member news (1123)
  • Agtech (29)
  • Digital health (38)
  • Industrial biotech (15)
  • Medical biotech (84)
  • Medtech (50)
  • Biovia (104)
  • BioVox (24)
  • Other news (18)

Tags

  • Research (63)
  • Collaborations (42)
  • Clinical / Field trials (41)
  • People (39)
  • Finance / Funding (37)
  • Innovation (37)
  • Patients (22)
  • Merger & Acquisition (10)
  • Infrastructure (7)
  • Software / IT / AI (7)

Year

  • 2026 (31)
  • 2025 (67)
  • 2024 (146)
  • (-) 2023 (211)
  • 2022 (201)
  • 2021 (223)
  • 2020 (244)
06 Jan 2023

UCB announces rozanolixizumab BLA for the treatment of generalized myasthenia gravis filed with U.S. FDA and designated for Priority Review

Member news

More info?

Ellen Telleir

Communications Project Manager
linkedin.com/in/ellentelleir/
ellen.telleir@biovia.be
Contact us
Ellen

Stay tuned about the latest updates in health innovation

Subscribe to our newsletter and receive regular updates.

Subscribe now

Contact us

  • info@biovia.be
  • BE1016 786 167
Home

Follow us

  • Youtube
  • LinkedIn

Voet

  • © 2026 | FBM vzw
  • Disclaimer
  • Privacy statement
  • Cookie policy
  • Domains
    • Human Health
    • Planetary Health
  • Members
  • Benefits
  • Funding
    • Project Call 2026.2
    • Intercluster cSBO call
    • Find a partner
  • Roadmaps
  • What's new
    • News
    • Events
    • Jobs
    • Science for Health
    • HealthTech Investor Summit
  • About Biovia
    • Mission & vision
    • Boards
    • Team
  • Contact
  • Become a member
  • Member portal